[PDF][PDF] Positron emission tomography for radiation treatment planning
AL Grosu, M Piert, WA Weber, B Jeremic… - Strahlentherapie und …, 2005 - academia.edu
Purpose: To evaluate the impact of positron emission tomography (PET) on target volume
delineation for radiation treatment planning. Material and Methods: The data of the literature …
delineation for radiation treatment planning. Material and Methods: The data of the literature …
Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications
KK Wong, M Piert - Journal of Nuclear Medicine, 2013 - Soc Nuclear Med
Dynamic bone scanning with 99m Tc-labeled diphosphonates and 18 F-labeled sodium
fluoride provides functional information sensitive for subtle changes in bone turnover and …
fluoride provides functional information sensitive for subtle changes in bone turnover and …
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated …
AL Grosu, WA Weber, M Franz, S Stärk, M Piert… - International Journal of …, 2005 - Elsevier
Purpose: To develop a valid treatment strategy for recurrent high-grade gliomas using
stereotactic hypofractionated reirradiation based on biologic imaging and temozolomide. Patients …
stereotactic hypofractionated reirradiation based on biologic imaging and temozolomide. Patients …
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside
M Piert, HJ Machulla, M Picchio, G Reischl… - Journal of Nuclear …, 2005 - Soc Nuclear Med
The study was performed to compare the 18 F-labeled nitroimidazole compound fluoroazomycin
arabinoside ( 18 F-FAZA) with the standard hypoxia tracer fluoromisonidazole ( 18 F-…
arabinoside ( 18 F-FAZA) with the standard hypoxia tracer fluoromisonidazole ( 18 F-…
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
…, JYC Wong, AR Pantel, SY Cho, KL Gage, M Piert… - Clinical Cancer …, 2021 - AACR
Purpose: Current FDA-approved imaging modalities are inadequate for localizing prostate
cancer biochemical recurrence (BCR). F-DCFPyL is a highly selective, small-molecule …
cancer biochemical recurrence (BCR). F-DCFPyL is a highly selective, small-molecule …
Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer
…, HJ Machulla, M Schwaiger, M Molls, M Piert - International Journal of …, 2007 - Elsevier
PURPOSE: To evaluate the role of hypoxia positron emission tomography (PET) using [ 18 F]fluoroazomycin-arabinoside
(FAZA) in head and neck cancer for radiation treatment …
(FAZA) in head and neck cancer for radiation treatment …
Extraosseous findings on bone scintigraphy using fusion SPECT/CT and correlative imaging
…, H Savas, A Kandathil, M Piert… - American Journal of …, 2015 - Am Roentgen Ray Soc
OBJECTIVE. Extraosseous radioactivity outside of the expected biodistribution is often
encountered on 99m Tc–methylene diphosphate (MDP) bone scintigraphy, and proper …
encountered on 99m Tc–methylene diphosphate (MDP) bone scintigraphy, and proper …
Assessment of porcine bone metabolism by dynamic [18F] fluoride ion PET: correlation with bone histomorphometry
M Piert, TT Zittel, GA Becker, M Jahn… - Journal of Nuclear …, 2001 - Soc Nuclear Med
The aim of this study was to quantify regional bone blood flow and [ 18 F]fluoride ion influx
with [ 18 F]fluoride ion PET and correlate the results with specific static and dynamic indices of …
with [ 18 F]fluoride ion PET and correlate the results with specific static and dynamic indices of …
In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging
…, R Meier, M Rudelius, G Piontek, M Piert… - European …, 2005 - Springer
The purpose of this study is to optimize labeling of the human natural killer (NK) cell line NK-92
with iron-oxide-based contrast agents and to monitor the in vivo distribution of genetically …
with iron-oxide-based contrast agents and to monitor the in vivo distribution of genetically …
[HTML][HTML] PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
…, DE Oprea-Lager, JR Osborne, M Piert… - European journal of …, 2023 - Springer
Here we aim to provide updated guidance and standards for the indication, acquisition, and
interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics …
interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics …